Enterprise Value to Revenue Multiple ratio Analysis of Biofil Chemicals & Pharmaceuticals Ltd. - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPoint
Beta&Vols
Tech ChartsEnterprise Value to Revenue Multiple of BIOFILCHEM
Mar-252.02Good EV to Revenue | Mar-242.40Good EV to Revenue | Growth-15.89% |
EV to Revenue Analysis of Biofil Chemicals & Pharmaceuticals Ltd.
| EV to Revenue Ratio of BIOFILCHEM has fallen by -15.89 % Compared to previous Financial Year. |
| EV to Revenue Ratio with value of 4.21 was highest in Year Mar-22 in last Five Years. |
| EV to Revenue Ratio of BIOFILCHEM trending down for at least three Years. |
| Latest EV to Revenue Ratio with value of 2.02 is lower than Average EV to Revenue of 2.86 in last five years. |
Other EV to Revenue Related Info of BIOFILCHEM that may interest you.
Biofil Chemicals & Pharmaceuticals Ltd. Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| BIOFILCHEM | 39.74 | 38.58 | 3.01 % | Drugs & Pharma |
Defination of Enterprise Value to Revenue Multiple
Enterprise Value to Revenue Ratio compares enterprise value with the company's total revenue. It indicates how much it costs investors relative to per unit of sales the company generates. more ..
EV to Revenue Related Ratios
| PriceToEarningRatio | EVToEBITDA | MarketCapToSalesRatio |
Tsr Value Index
| Poor Value Stock | Screener |
FY - Historical Enterprise Value to Revenue Multiple of Biofil Chemicals & Pharmaceuticals Ltd.
| Period | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 |
|---|---|---|---|---|---|---|---|
| EV to Revenue | 2.02 | 2.40 | 2.68 | 4.21 | 3.00 | 0.402 | 0.554 |
| Change | -15.89 % | -10.52 % | -36.38 % | 40.43 % | 644.73 % | -27.34 % | -71.14 % |
| Price | 41.16 | 60.60 | 41.40 | 57.65 | 65.85 | 7.50 | 6.95 |
| Price Change | -32.08 % | 46.38 % | -28.19 % | -12.45 % | 778.00 % | 7.91 % | -49.82 % |